Mapping the Immune Battlefield with an In Vivo CRISPR/Cas9 Screen
Source PublicationJournal of Experimental Medicine
Primary AuthorsCalderón, Schäfer, Rončević et al.

The invasion begins in silence. A pathogen breaches the perimeter, finding a foothold in the warm, obscured depths of the host. It multiplies, unchecked. The body’s survival depends on a precise, violent counter-attack, yet the battlefield is chaotic. Deep within the spleen, a frantic recruitment drive must occur. Naïve B cells, the dormant defenders, must wake. They must change their very nature, swelling into plasmablasts—biological foundries that pump out antibodies to neutralise the threat. But this metamorphosis is fraught with peril. It is a fragile, high-stakes decision tree.
For years, the specific signals guiding this transformation remained shadowed by the sheer noise of the living organism. In the sterile quiet of a plastic dish, cells behave politely. In the throbbing, blood-fed reality of a mouse, they are wild. This discrepancy has been the antagonist of immunology. We could not see the true commanders of the fleet because we were looking at a map, not the territory. The complexity of the living environment hid the truth, shielding the molecular logic that stands between survival and septic collapse.
Deploying an In Vivo CRISPR/Cas9 Screen
To pierce this biological fog, researchers engineered a solution that operates within the storm. They did not remove the cells to a safe haven; they brought the genetic tools to the front lines. The team developed a specialised mouse model, the Cd23-Cre, which expresses a specific receptor allowing for efficient gene editing directly in naïve B cells. This setup enabled a pooled in vivo CRISPR/Cas9 screen, a method that tests hundreds of genes simultaneously within the animal itself.
Upon immunisation, the researchers tracked 379 specific gene targets. They watched to see which genetic edits would help the B cells become plasma cells and which would cause them to fail. The screen offered a raw, unfiltered look at immune regulation.
Unexpected Architects of Defence
The results provided a plot twist in our understanding of cellular logistics. The screen identified 23 positive and 18 negative regulators that might have remained invisible in a test tube. Surprisingly, the hit list included genes responsible for iron transport and protein folding. These are not merely housekeeping functions; the data implies they are active directors of the immune response.
Proteins involved in cell adhesion and signal transduction also emerged as essential players. This suggests that the physical stickiness of a cell and its ability to process heavy metals are just as vital to fighting infection as the classic immune genes we already knew. By studying the system in its native context, the team exposed a layer of regulation that dictates whether the body wins the war or succumbs to the invader.